Primary vasculitides – current diagnostics and therapy

Czech version

Authors: Radim Bečvář
Authors‘ workplace: Revmatologický ústav a Revmatologická klinika 1. LF UK, Praha
Published in: Čes.-slov. Patol., 56, 2020, No. 2, p. 74-82
Category: Reviews Article

Overview

By term „vasculitis“ inflammatory disease of blood vessels is designated that leads to vessel wall destruction followed by proliferation and occlusion of their lumina. Basic condition for this diagnosis is that vessel wall is a primary site of the pathological process. Clinical syndromes are a consequence of this process resulting into ischaemia of tissues supplied by the affected vessels and with constitutional symptoms associated to the inflammatory disease. Vasculitis can occur de novo as a primary involvement of vessel wall of unknown aetiology or it develops secondary to other diseases. The diagnosis of vasculitis is usually based on pathological findings from biopsy or abnormalities detected by imaging methods. This review describes the common primary vasculitides, their diagnostics and management.

Keywords:

vasculitis – arteritis – angiogramy – Biopsy – immunosuppression

Sources

Bečvář R, Tesař V, Rychlík I. Vaskulitidy v klinické praxi - diagnostika a terapie. (1. vyd) Praha: Medprint; 1994, 8-9.
Ansell BM, Bacon PA, Lie JT, Yazici H. The vasculitides. Science and practice (1st ed). London: Chapman&Hall Medical; 1996: 267-269.
Fessler BJ. Approach to the diagnosis of vasculitis in adult patients. In: Ball GV, Louis Bridge S Jr, eds. Vasculitis (2^nd ed). Oxford: Oxford University Press; 2008: 277-284.
Alvarez-Lafuente R, Fernández-Gutiérrez B, Jover JA et al. Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction. Ann Rheum Dis 2005; 64: 780-782.
Hunder GG, Bloch DA, Michel BA et al. The American College of Rheumatology 1990 revised criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122-1128.
Dejaco C, Duftner C, Buttgereit F, Matteson EL, Dasgupta B. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology (Oxford) 2017; 56: 506-515.
Mukhtyar C, Guillevin, Cid MC et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009; 68: 318-323.
Hall S, Buchbinder R. Takayasu‘s arteritis. Rheum Dis Clin North Amer 1990; 16: 411-422.
Kobayashi Y. Takayasu‘s arteritis. In: Ball GV, Louis Bridges S Jr, eds. Vasculitis (2^nd ed). Oxford: Oxford University Press; 2008: 325-327.
Hunder GG, Bloch DA, Michel BA et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu‘s arteritis. Arthritis Rheum 1990; 33: 1129-1134.
Hellmich B, Agueda A, Monti S et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2019 Jul 3. pii: annrheumdis-2019-215672. doi: 10.1136/annrheumdis-2019-215672. [Epub ahead of print].
De Virgilio A, Greco A, Magliulo G et al. Polyarteritis nodosa: A contemporary overview. Autoimmun Rev 2016; 15: 564-570.
Pagnoux C, Seror R, Henegar C for the French Vasculitis Study Group. Clinical Features and Outcomes in 348 Patients With Polyarteritis Nodosa A Systematic Retrospective Study of Patients Diagnosed Between 1963 and 2005 and Entered Into the French Vasculitis Study Group Database. Arthritis Rheum 2010; 62: 616–662.
Henegar C, Pagnoux C, Puéchal X for the French Vasculitis Study Group. A paradigm of diagnostic criteria for polyarteritis nodosa: analysis of a series of 949 patients with vasculitides. Arthritis Rheum 2008; 58:1528-1538.
Guillevin L, Pagnoux C, Teixeira L. Treatment of PAN. In: Ball GV, Louis Bridges S Jr, eds. Vasculitis (2^nd ed). Oxford: Oxford University Press; 2008: 347-349
Hoffman GS, Weyand CM et al. Inflammatory diseases of blood vessels. (1st ed.). New York: Marcel Dekker, Inc, 2002: 306-368.
Clain JM, Hummel AM, Stone JH et al. Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis. Clin Exp Immunol 2017; 188: 174-181.
Nikkari RA, Vainionpää R, Toivanen P et al. Wegener‘s granulomatosis and parvovirus B19 infection. Arthritis Rheum 1995; 38: 1175-1176.
Hoffman GS, Kerr GS, Leavitt RY et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488–498.
Csernok E, Holle J, Hellmich B et al. Evaluation of capture ELISA for detection of neutrophil cytoplasmic antibodies directed against proteinase 3 in Wegeners granulomatosis: first results from a multicenter study. Rheumatology (Oxford) 2004; 43: 174-180.
Smith RM, Jones RB, Jayne DR. Progress in treatment of ANCA-associated vasculitis. Arthritis Res Ther 2012; 4: 210-213.
Specks U. Churg-Strauss syndrome In: Ball GV, Louis Bridges S Jr, eds. Vasculitis (2^nd ed). Oxford: Oxford University Press; 2008: 429-438.
Zhou XL, Zheng MJ, Shuai ZW et al. The significances of peripheral neutrophils CD(55) and myeloperoxidase expression in patients with myeloperoxidase-specific anti-neutrophil cytoplasmic antibody associated vasculitis. Zhonghua Nei Ke Za Zhi 2017; 56: 427-432.
Bečvář R. Moderní terapie ANCA pozitivních vaskulitid. Acta medicinae 2013; 2: 76-79.
Fresko I, Melikoglu M, Kural-Seyahi E et al. Behçet’syndrome: pathogenesis, clinical manifestations, and treatment. In: Ball GV, Louis Bridges S Jr, eds. Vasculitis (2^nd ed). Oxford: Oxford University Press; 2008: 461-474.
International Study Group for Behçets disease. Criteria for diagnosis of Behcet‘s disease. Lancet 1990; 335: 1078-1080.
Hatemi G, Silman A, Bang D and EULAR Expert Committee. EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 2008; 67: 1656-1662.
Calvino MC, Llorca J, Garcia-Porrú AC et al. Henoch-Schönlein purpura in childern in north western Spain: a 20-year epidemiologic and clinical study. Medicine (Baltimore) 2001; 80: 279-290.
Ozen S, Marks SD, Brogan P et al. European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford). 2019; 58: 1607-1616.
Bogdanović R. Henoch-Schönlein purpura nephritis in children: risk factors, prevention and treatment. Acta Paediatr 2009; 98: 1882-1889.